1. Home
  2. TENX vs SANW Comparison

TENX vs SANW Comparison

Compare TENX & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • SANW
  • Stock Information
  • Founded
  • TENX 1967
  • SANW 1980
  • Country
  • TENX United States
  • SANW United States
  • Employees
  • TENX 6
  • SANW N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • SANW Farming/Seeds/Milling
  • Sector
  • TENX Health Care
  • SANW Consumer Staples
  • Exchange
  • TENX Nasdaq
  • SANW Nasdaq
  • Market Cap
  • TENX 21.6M
  • SANW 18.8M
  • IPO Year
  • TENX N/A
  • SANW 2010
  • Fundamental
  • Price
  • TENX $5.53
  • SANW $4.72
  • Analyst Decision
  • TENX Strong Buy
  • SANW Strong Buy
  • Analyst Count
  • TENX 3
  • SANW 1
  • Target Price
  • TENX $16.00
  • SANW $35.00
  • AVG Volume (30 Days)
  • TENX 18.4K
  • SANW 5.6K
  • Earning Date
  • TENX 05-13-2025
  • SANW 05-13-2025
  • Dividend Yield
  • TENX N/A
  • SANW N/A
  • EPS Growth
  • TENX N/A
  • SANW N/A
  • EPS
  • TENX N/A
  • SANW N/A
  • Revenue
  • TENX N/A
  • SANW $54,809,365.00
  • Revenue This Year
  • TENX N/A
  • SANW N/A
  • Revenue Next Year
  • TENX N/A
  • SANW $14.25
  • P/E Ratio
  • TENX N/A
  • SANW N/A
  • Revenue Growth
  • TENX N/A
  • SANW N/A
  • 52 Week Low
  • TENX $2.77
  • SANW $2.10
  • 52 Week High
  • TENX $7.89
  • SANW $11.60
  • Technical
  • Relative Strength Index (RSI)
  • TENX 42.57
  • SANW 31.49
  • Support Level
  • TENX $4.63
  • SANW $4.55
  • Resistance Level
  • TENX $5.75
  • SANW $4.84
  • Average True Range (ATR)
  • TENX 0.42
  • SANW 0.43
  • MACD
  • TENX -0.04
  • SANW -0.03
  • Stochastic Oscillator
  • TENX 47.70
  • SANW 20.62

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

Share on Social Networks: